Cargando…
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762900/ https://www.ncbi.nlm.nih.gov/pubmed/36480479 http://dx.doi.org/10.15585/mmwr.mm7149a5 |
_version_ | 1784852947111247872 |
---|---|
author | Payne, Amanda B. Ray, Logan C. Cole, Matthew M. Canning, Michelle Houck, Kennedy Shah, Hazel J. Farrar, Jennifer L. Lewis, Nathaniel M. Fothergill, Amy White, Elizabeth B. Feldstein, Leora R. Roper, Lauren E. Lee, Florence Kriss, Jennifer L. Sims, Emily Spicknall, Ian H. Nakazawa, Yoshinori Gundlapalli, Adi V. Shimabukuro, Tom Cohen, Adam L. Honein, Margaret A. Mermin, Jonathan Payne, Daniel C. |
author_facet | Payne, Amanda B. Ray, Logan C. Cole, Matthew M. Canning, Michelle Houck, Kennedy Shah, Hazel J. Farrar, Jennifer L. Lewis, Nathaniel M. Fothergill, Amy White, Elizabeth B. Feldstein, Leora R. Roper, Lauren E. Lee, Florence Kriss, Jennifer L. Sims, Emily Spicknall, Ian H. Nakazawa, Yoshinori Gundlapalli, Adi V. Shimabukuro, Tom Cohen, Adam L. Honein, Margaret A. Mermin, Jonathan Payne, Daniel C. |
author_sort | Payne, Amanda B. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9762900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-97629002022-12-23 Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 Payne, Amanda B. Ray, Logan C. Cole, Matthew M. Canning, Michelle Houck, Kennedy Shah, Hazel J. Farrar, Jennifer L. Lewis, Nathaniel M. Fothergill, Amy White, Elizabeth B. Feldstein, Leora R. Roper, Lauren E. Lee, Florence Kriss, Jennifer L. Sims, Emily Spicknall, Ian H. Nakazawa, Yoshinori Gundlapalli, Adi V. Shimabukuro, Tom Cohen, Adam L. Honein, Margaret A. Mermin, Jonathan Payne, Daniel C. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-12-09 /pmc/articles/PMC9762900/ /pubmed/36480479 http://dx.doi.org/10.15585/mmwr.mm7149a5 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
spellingShingle | Full Report Payne, Amanda B. Ray, Logan C. Cole, Matthew M. Canning, Michelle Houck, Kennedy Shah, Hazel J. Farrar, Jennifer L. Lewis, Nathaniel M. Fothergill, Amy White, Elizabeth B. Feldstein, Leora R. Roper, Lauren E. Lee, Florence Kriss, Jennifer L. Sims, Emily Spicknall, Ian H. Nakazawa, Yoshinori Gundlapalli, Adi V. Shimabukuro, Tom Cohen, Adam L. Honein, Margaret A. Mermin, Jonathan Payne, Daniel C. Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 |
title | Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 |
title_full | Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 |
title_fullStr | Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 |
title_full_unstemmed | Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 |
title_short | Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 |
title_sort | reduced risk for mpox after receipt of 1 or 2 doses of jynneos vaccine compared with risk among unvaccinated persons — 43 u.s. jurisdictions, july 31–october 1, 2022 |
topic | Full Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762900/ https://www.ncbi.nlm.nih.gov/pubmed/36480479 http://dx.doi.org/10.15585/mmwr.mm7149a5 |
work_keys_str_mv | AT payneamandab reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT rayloganc reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT colematthewm reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT canningmichelle reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT houckkennedy reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT shahhazelj reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT farrarjenniferl reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT lewisnathanielm reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT fothergillamy reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT whiteelizabethb reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT feldsteinleorar reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT roperlaurene reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT leeflorence reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT krissjenniferl reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT simsemily reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT spicknallianh reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT nakazawayoshinori reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT gundlapalliadiv reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT shimabukurotom reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT cohenadaml reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT honeinmargareta reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT merminjonathan reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 AT paynedanielc reducedriskformpoxafterreceiptof1or2dosesofjynneosvaccinecomparedwithriskamongunvaccinatedpersons43usjurisdictionsjuly31october12022 |